These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 8372831)
1. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Fogo A; Qureshi N; Horn RG Am J Kidney Dis; 1993 Sep; 22(3):367-77. PubMed ID: 8372831 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis. Grove P; Neale PH; Peck M; Schiller B; Haas M Mod Pathol; 1998 Jan; 11(1):103-9. PubMed ID: 9556416 [TBL] [Abstract][Full Text] [Related]
3. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361 [TBL] [Abstract][Full Text] [Related]
4. Immunotactoid glomerulopathy. Korbet SM; Schwartz MM; Rosenberg BF; Sibley RK; Lewis EJ Medicine (Baltimore); 1985 Jul; 64(4):228-43. PubMed ID: 4010500 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. Markowitz GS; Cheng JT; Colvin RB; Trebbin WM; D'Agati VD J Am Soc Nephrol; 1998 Dec; 9(12):2244-52. PubMed ID: 9848778 [TBL] [Abstract][Full Text] [Related]
6. Fibrillary-immunotactoid glomerulopathy with renal deposits of IgAlambda: a rare cause of glomerulonephritis. van Ginneken EE; Assmann KJ; Koolen MI; Jansen JL; Wetzels JF Clin Nephrol; 1999 Dec; 52(6):383-9. PubMed ID: 10604647 [TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic features of fibrillary glomerulonephritis. Iskandar SS; Falk RJ; Jennette JC Kidney Int; 1992 Dec; 42(6):1401-7. PubMed ID: 1474772 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological analysis of fibrillary glomerulopathy]. Zhang Y; Wang S; Zou W Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):367-70. PubMed ID: 8582180 [TBL] [Abstract][Full Text] [Related]
9. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Alpers CE Am J Kidney Dis; 1992 Feb; 19(2):185-91. PubMed ID: 1739104 [TBL] [Abstract][Full Text] [Related]
10. Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy. Pronovost PH; Brady HR; Gunning ME; Espinoza O; Rennke HG Nephrol Dial Transplant; 1996 May; 11(5):837-42. PubMed ID: 8671905 [TBL] [Abstract][Full Text] [Related]
12. [Immunotactoid glomerulopathy]. Wang S; Zhang Y; Zou W Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):688-90. PubMed ID: 9275553 [TBL] [Abstract][Full Text] [Related]
13. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Bridoux F; Hugue V; Coldefy O; Goujon JM; Bauwens M; Sechet A; Preud'Homme JL; Touchard G Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978 [TBL] [Abstract][Full Text] [Related]
15. Glomerulopathies with Fibrillary Deposits. Dzekova-Vidimliski P; Karanfilovski V; Nikolov IG; Rambabova-Bushljetik I; Ristovska V; Petrushevska G; Selim G Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Jul; 44(2):99-106. PubMed ID: 37453107 [TBL] [Abstract][Full Text] [Related]
16. Fibrillary (immunotactoid) glomerulopathy. A possible role for kappa light chain in its etiology and/or pathogenesis. Esparza AR; Chazan JA; Nayak RN; Cavallo T Am J Surg Pathol; 1991 Jul; 15(7):632-43. PubMed ID: 1905497 [TBL] [Abstract][Full Text] [Related]
17. Immunotactoid glomerulopathy in a child with Down syndrome. Takemura T; Yoshioka K; Akano N; Michihata I; Okada M; Maki S; Shigematsu H Pediatr Nephrol; 1993 Feb; 7(1):86-8. PubMed ID: 8439490 [TBL] [Abstract][Full Text] [Related]